News | Orthopedic Imaging | September 06, 2017

All four of the most common MSK modalities saw increases, led by CT at 754 percent

Musculoskeletal Extremity Imaging in Medicare Beneficiaries Increased Over Two Decades

September 6, 2017 — A new study by the Harvey L. Neiman Health Policy Institute found that in the Medicare population, the utilization rates have increased in both volume and per beneficiary over the past two decades for the most common musculoskeletal (MSK) extremity imaging modalities. The study focused on radiography, magnetic resonance imaging (MRI), computed tomography (CT) and ultrasound.

Radiology was the dominant billing specialty for all imaging modalities with dominant market shares for MRI and CT. Physician offices were the most common site for imaging for all modalities except for CT, which was most commonly utilized in the hospital outpatient and inpatient settings. These insights may have implications for radiology practice leaders in making decisions regarding capital infrastructure, workforce and training investments to ensure the provision of optimal imagine services for extremity musculoskeletal care.

The study is published online in the American Journal of Roentgenology. 

“Our results show that the utilization rates (per 1,000 Medicare beneficiaries) for all four musculoskeletal extremity imaging modalities increased over time,” said lead study author Soterios Gyftopoulos, M.D., an associate professor of radiology at NYU Langone Medical Center. “The largest increase was for CT throughout our study’s time period with a 754 percent increase in utilization from 1994 to 2013.”

Gyftopoulos and his colleagues used billing data obtained from Centers for Medicare and Medicaid Services (CMS) Medicare Physician Supplier Procedure Summary Master Files from 1994 to 2013. The Neiman Imaging Types of Service (NITOS) radiology claims classification system was used to identify those HCPS codes corresponding with non-vascular extremity imaging. The following increases in MSK extremity imaging were found over the past two decades: 43 percent for radiography, 619 percent for MRI, 754 percent for CT and 528 percent for ultrasound. 

“An understanding of the utilization rates of common imaging modalities is an important first step toward determining the most cost-effective imaging strategies for patients with musculoskeletal conditions," added Richard Duszak, M.D., FACR, professor and vice chair for health policy and practice in the department of radiology and imaging sciences at Emory University and senior affiliate research fellow at the Neiman Institute. “Our findings support observations that physicians are increasingly relying on advanced imaging to ensure that their patients with musculoskeletal diseases receive the best care,” he said.

Read the article "CMS May Cancel Orthopedic and Cardiac Bundled Payments."

For more information: www.ajronline.org


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Artificial Intelligence

June 11, 2024 — A new study led by researchers at Emory AI.Health, published in the Journal of Computers in Medicine and ...

Time June 11, 2024
arrow
News | Breast Imaging

June 7, 2024 — Scholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization ...

Time June 07, 2024
arrow
News | Radiopharmaceuticals and Tracers

June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...

Time June 07, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
News | Prostate Cancer

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
News | Pediatric Imaging

May 2, 2024 — Head and abdominal trauma is a leading cause of death for children. About 1%–2% of children who come to ...

Time May 02, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
Subscribe Now